Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer

被引：0
|
作者：
Dmitriy I Dovzhanskiy
Stefanie M Arnold
Thilo Hackert
Ina Oehme
Olaf Witt
Klaus Felix
Nathalia Giese
Jens Werner
机构：
[1] University of Heidelberg,Department of General Surgery
[2] German Cancer Research Center (DKFZ),Department of Pediatric Oncology
[3] University of Heidelberg Medical Center,undefined
来源：
BMC Cancer | / 12卷
关键词：
Pancreatic cancer; Histone deacetylase inhibitors; Belinostat; Mice;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
    Dovzhanskiy, Dmitriy I.
    Arnold, Stefanie M.
    Hackert, Thilo
    Oehme, Ina
    Witt, Olaf
    Felix, Klaus
    Giese, Nathalia
    Werner, Jens
    BMC CANCER, 2012, 12
  • [2] The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
    Michael T Buckley
    Joanne Yoon
    Herman Yee
    Luis Chiriboga
    Leonard Liebes
    Gulshan Ara
    Xiaozhong Qian
    Dean F Bajorin
    Tung-Tien Sun
    Xue-Ru Wu
    Iman Osman
    Journal of Translational Medicine, 5
  • [3] The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
    Buckley, Michael T.
    Yoon, Joanne
    Yee, Herman
    Chiriboga, Luis
    Liebes, Leonard
    Ara, Gulshan
    Qian, Xiaozhong
    Bajorin, Dean F.
    Sun, Tung-Tien
    Wu, Xue-Ru
    Osman, Iman
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [4] Growth Inhibition of Pancreatic Cancer Cells by Histone Deacetylase Inhibitor Belinostat Through Suppression of Multiple Pathways Including HIF, NFkB, and mTOR Signaling In Vitro and In Vivo
    Chien, Wenwen
    Lee, Dhong Hyun
    Zheng, Yun
    Wuensche, Peer
    Alvarez, Rosie
    Wen, Ding Ling
    Aribi, Ahmed M.
    Thean, Su Ming
    Doan, Ngan B.
    Said, Jonathan W.
    Koeffler, H. Phillip
    MOLECULAR CARCINOGENESIS, 2014, 53 (09) : 722 - 735
  • [5] Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo
    Liu, Xinyu
    Li, Wenjing
    Xu, Licheng
    Chen, Xiaoxue
    Zhao, Rui
    Guo, Yan
    Ge, Jingchun
    Yang, Zhenming
    Li, Liang
    Zhang, Jiarui
    Cao, Jing
    Shao, Yue
    Guo, Xinyue
    Tian, Linli
    Liu, Ming
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 158
  • [6] Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor
    Gimsing, Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 501 - 508
  • [7] Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer
    Martin, Darryl T.
    Hoimes, Christopher J.
    Kaimakliotis, Hristos Z.
    Cheng, Christopher J.
    Zhang, Ke
    Liu, Jingchun
    Wheeler, Marcia A.
    Kelly, W. Kevin
    Tew, Greg N.
    Saltzman, W. Mark
    Weiss, Robert M.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (08) : 1124 - 1134
  • [8] Histone Deacetylase Inhibitor Valproic Acid Inhibits MiaPaCa2 Cells Growth in vitro and in vivo: a New Promising Class of Anti-neoplasic Agents in Pancreatic Cancer?
    Machado, M. C. C.
    Kubrusly, M. S.
    Molan, N. T.
    D'Albuquerque, L. A. C.
    PANCREAS, 2011, 40 (08) : 1336 - 1336
  • [9] HISTONE DEACETYLASE INHIBITOR, VALPROIC ACID INHIBITS GLIOMA ANGIOGENESIS IN VITRO AND IN VIVO IN THE BRAIN
    Osuka, Satoru
    Takano, Shingo
    Yamamoto, Tetsuya
    Ishikawa, Eiichi
    Matsumura, Akira
    NEURO-ONCOLOGY, 2009, 11 (06) : 962 - 962
  • [10] Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
    Hrzenjak, Andelko
    Moinfar, Farid
    Kremser, Marie-Luise
    Strohmeier, Bettina
    Petru, Edgar
    Zatloukal, Kurt
    Denk, Helmut
    MOLECULAR CANCER, 2010, 9
12345